These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11477561)

  • 1. MHC class I negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in R0M0 breast cancer patients.
    Zia A; Schildberg FW; Funke I
    Int J Cancer; 2001 Aug; 93(4):566-70. PubMed ID: 11477561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells.
    Pantel K; Schlimok G; Kutter D; Schaller G; Genz T; Wiebecke B; Backmann R; Funke I; Riethmüller G
    Cancer Res; 1991 Sep; 51(17):4712-5. PubMed ID: 1873815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
    Andratschke M; Pauli C; Stein M; Chaubal S; Wollenberg B
    Anticancer Res; 2003; 23(2B):1467-71. PubMed ID: 12820411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor expression profile of disseminated epithelial tumor cells in bone marrow of breast cancer patients.
    Ditsch N; Mayer B; Rolle M; Untch M; Schildberg FW; Funke I
    Recent Results Cancer Res; 2003; 162():141-7. PubMed ID: 12790328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance.
    Schlimok G; Funke I; Bock B; Schweiberer B; Witte J; Riethmüller G
    J Clin Oncol; 1990 May; 8(5):831-7. PubMed ID: 1692090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells.
    Pantel K; Schlimok G; Braun S; Kutter D; Lindemann F; Schaller G; Funke I; Izbicki JR; Riethmüller G
    J Natl Cancer Inst; 1993 Sep; 85(17):1419-24. PubMed ID: 7688814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.
    Pantel K; Schlimok G; Angstwurm M; Weckermann D; Schmaus W; Gath H; Passlick B; Izbicki JR; Riethmüller G
    J Hematother; 1994; 3(3):165-73. PubMed ID: 7530132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
    J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.
    Schlimok G; Funke I; Holzmann B; Göttlinger G; Schmidt G; Häuser H; Swierkot S; Warnecke HH; Schneider B; Koprowski H; Riethmüller G
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8672-6. PubMed ID: 2446326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
    Jauch KW; Heiss MM; Gruetzner U; Funke I; Pantel K; Babic R; Eissner HJ; Riethmueller G; Schildberg FW
    J Clin Oncol; 1996 Jun; 14(6):1810-7. PubMed ID: 8656249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.
    Thorban S; Roder JD; Nekarda H; Funk A; Siewert JR; Pantel K
    J Natl Cancer Inst; 1996 Sep; 88(17):1222-7. PubMed ID: 8780632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
    Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
    Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-MUC1 monoclonal antibody BCP8 can be used to isolate and identify putative major histocompatibility complex class I associated amino acid sequences.
    Agrawal B; Reddish MA; Christian B; VanHeele A; Tang L; Koganty RR; Longenecker BM
    Cancer Res; 1998 Nov; 58(22):5151-6. PubMed ID: 9823326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumour cells.
    Passlick B; Pantel K; Kubuschok B; Angstwurm M; Neher A; Thetter O; Schweiberer L; Izbicki JR
    Eur J Cancer; 1996 Jan; 32A(1):141-5. PubMed ID: 8695222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.
    Goepel JR; Rees RC; Rogers K; Stoddard CJ; Thomas WE; Shepherd L
    Br J Cancer; 1991 Nov; 64(5):880-3. PubMed ID: 1718386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
    Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
    Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer.
    Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
    Ann Thorac Surg; 1999 Dec; 68(6):2053-8. PubMed ID: 10616976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: unusually high frequency of down-regulation in breast cancer tissues.
    Torigoe T; Asanuma H; Nakazawa E; Tamura Y; Hirohashi Y; Yamamoto E; Kanaseki T; Hasegawa T; Sato N
    Pathol Int; 2012 May; 62(5):303-8. PubMed ID: 22524657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of micrometastasis in bone marrow of pancreatic cancer patients.
    Thorban S; Roder JD; Siewert JR
    Ann Oncol; 1999; 10 Suppl 4():111-3. PubMed ID: 10436799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total loss of MHC class I is an independent indicator of good prognosis in breast cancer.
    Madjd Z; Spendlove I; Pinder SE; Ellis IO; Durrant LG
    Int J Cancer; 2005 Nov; 117(2):248-55. PubMed ID: 15900607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.